By hindering the nuclear transport and DNA-binding capacity of NF-κB, TRIM3 effectively deactivates this signaling pathway and downregulates the downstream target genes, such as IL-6 and TNF-α, thus curbing the inflammatory response and invasion abilities of colorectal cancer cells (Zhu et al. 2023). This evidence concerns the gene NFKB1 and colorectal cancer.